JaNae Holloway
Biographic Data
| ID | 6063235 |
|---|---|
| NAME | JaNae Holloway |
| GIVEN NAMES | JaNae |
| FAMILY NAME | Holloway |
| SIGNATURE | HOLLOWAY J |
| AFFILIATIONS | RTI International |
| ORCID | 0009-0009-1609-8237 |
| VERIFIED | Yes |
| TOTAL WORKS | 4 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 4 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2023 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Reach of Community-Selected Strategies to Reduce Opioid-Related Overdose Deaths in the Healing Communities Study
INTRODUCTION: Despite recent declines, the U.S. opioid overdose crisis persists. The HEALing Communities Study (HCS) aimed to reduce opioid overdose deaths through community-level adoption of evidence-based practices (EBPs), including overdose education and naloxone distribution (OEND) and medications for opioid use disorder (MOUD). This paper describes the reach of OEND and MOUD strategies implemented by the 33 HCS wait-list control communities.…
Overdose education and naloxone distribution in jails
BACKGROUND: Opioid-related overdose is the leading cause of mortality among individuals recently released from incarceration in the U.S. Naloxone is an FDA-approved opioid antagonist medication designed to rapidly reverse opioid overdose. Despite evidence of its acceptability and effectiveness at reducing the risk of opioid overdose death after release from incarceration, only an estimated 25% of US jails provide naloxone upon release. This study…
Effect of the Communities That Heal Intervention on Overdose Education and Naloxone Distribution
Objectives. To determine whether the Communities That HEAL (CTH) intervention is effective in increasing naloxone distribution compared with usual care. Methods. The HEALing (Helping to End Addiction Long-Term) Communities Study (HCS) is a cluster-randomized, parallel-arm, wait-list controlled implementation science trial testing the impact of the CTH intervention on increasing the use of evidence-based practices to lower opioid-related overdose …
Community-level determinants of stakeholder perceptions of community stigma toward people with opioid use disorders, harm reduction services and treatment in the Healing Communities Study
No prominent works on this page.
Community-level determinants of stakeholder perceptions of community stigma toward people with opioid use disorders, harm reduction services and treatment in the Healing Communities Study
Overdose education and naloxone distribution in jails
BACKGROUND: Opioid-related overdose is the leading cause of mortality among individuals recently released from incarceration in the U.S. Naloxone is an FDA-approved opioid antagonist medication designed to rapidly reverse opioid overdose. Despite evidence of its acceptability and effectiveness at reducing the risk of opioid overdose death after release from incarceration, only an estimated 25% of US jails provide naloxone upon release. This study…
Effect of the Communities That Heal Intervention on Overdose Education and Naloxone Distribution
Objectives. To determine whether the Communities That HEAL (CTH) intervention is effective in increasing naloxone distribution compared with usual care. Methods. The HEALing (Helping to End Addiction Long-Term) Communities Study (HCS) is a cluster-randomized, parallel-arm, wait-list controlled implementation science trial testing the impact of the CTH intervention on increasing the use of evidence-based practices to lower opioid-related overdose …
Reach of Community-Selected Strategies to Reduce Opioid-Related Overdose Deaths in the Healing Communities Study
INTRODUCTION: Despite recent declines, the U.S. opioid overdose crisis persists. The HEALing Communities Study (HCS) aimed to reduce opioid overdose deaths through community-level adoption of evidence-based practices (EBPs), including overdose education and naloxone distribution (OEND) and medications for opioid use disorder (MOUD). This paper describes the reach of OEND and MOUD strategies implemented by the 33 HCS wait-list control communities.…
HIV, Drug Use, Sexual Risk (4 works) · Medicine (4 works) · Opioid (4 works) · Opioid Use Disorder Treatment (4 works) · Psychiatry (4 works) · Substance Abuse Treatment and Outcomes (4 works) · Psychology (3 works) · Environmental health (2 works) · Gerontology (2 works) · Internal Medicine (2 works)